{
    "references": [
        {
            "bibentry": "Kerr, JF, Wyllie, AH, Currie, AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57. PMID: 4561027",
            "process_entry": "True",
            "doi": "10.1038/bjc.1972.33",
            "pmid": "4561027",
            "pmcid": "PMC2008650",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Fischer, U, Janssen, K, Schulze-Osthoff, K. Cutting-edge apoptosis-based therapeutics. Biodrugs 2007; 21: 273–97. PMID: 17896835",
            "process_entry": "True",
            "doi": "10.2165/00063030-200721050-00001",
            "pmid": "17896835",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Chen, Z, Liang, X, Zhang, H, et al. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis. J Med Chem 2010; 53: 2589–600. PMID: 20170164",
            "process_entry": "True",
            "doi": "10.1021/jm100025u",
            "pmid": "20170164",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Tian, Z, Xie, S, Du, Y, et al. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents. Eur J Med Chem 2009; 44: 393–9. PMID: 18423800",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2008.02.044",
            "pmid": "18423800",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Bredesen, DE. Apoptosis: overview and signal transduction pathways. J Neurotrauma 2000; 17: 801–10. PMID: 11063049",
            "process_entry": "True",
            "doi": "10.1089/neu.2000.17.801",
            "pmid": "11063049",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "DeSantis, C, Ma, J, Bryan, L, Jemal, A. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64: 52–62. PMID: 24114568",
            "process_entry": "True",
            "doi": "10.3322/caac.21203",
            "pmid": "24114568",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Slamon, DJ, Clark, GM, Wong, SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–82. PMID: 3798106",
            "process_entry": "True",
            "doi": "10.1126/science.3798106",
            "pmid": "3798106",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Clauditz, TS, Gontarewicz, A, Lebok, P, et al. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target. Oral Oncol 2012; 48: 991–6. PMID: 22694907",
            "process_entry": "True",
            "doi": "10.1016/j.oraloncology.2012.05.005",
            "pmid": "22694907",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Arteaga, CL, Engelman, JA. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 2014; 25: 282–303. PMID: 24651011",
            "process_entry": "True",
            "doi": "10.1016/j.ccr.2014.02.025",
            "pmid": "24651011",
            "pmcid": "PMC4018830",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Ohashi, K, Sequist, LV, Arcila, ME, et al. Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res 2013; 19: 1–8.",
            "process_entry": "True",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Narayan, M, Wilken, JA, Harris, LN, et al. Trastuzumab-induced HER reprogramming in “resistant” breast carcinoma cells. Cancer Res 2009; 69: 2191–4. PMID: 19276389",
            "process_entry": "True",
            "doi": "10.1158/0008-5472.can-08-1056",
            "pmid": "19276389",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Olayioye, MA, Neve, RM, Lane, HA, Hynes, NE. The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J 2000; 19: 3159–67. PMID: 10880430",
            "process_entry": "True",
            "doi": "10.1093/emboj/19.13.3159",
            "pmid": "10880430",
            "pmcid": "PMC313958",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Nagarsenkar, A, Prajapti, SK, Guggilapu, SD, et al. Investigation of triazole-linked indole and oxindole glycoconjugates as potential anticancer agents: novel Akt/PKB signaling pathway inhibitors. Med Chem Comm 2016; 7: 646–53.",
            "process_entry": "True",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Alsaid, MS, Al-Mishari, AA, Soliman, AM, et al. Discovery of benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. Eur J Med Chem 2017; 141: 84–91. PMID: 29028534",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.09.061",
            "pmid": "29028534",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Ghorab, MM, Alsaid, MS, Soliman, AM, Al-Mishari, AA. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem 2018; 33: 67–73. PMID: 29098904",
            "process_entry": "True",
            "doi": "10.1080/14756366.2017.1389922",
            "pmid": "29098904",
            "pmcid": "PMC6010119",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Elkamhawy, A, Farag, AK, Viswanath, ANI, et al. Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: design, synthesis, kinase assay, cell-based assay, and molecular docking. Bioorg Med Chem Lett 2015; 25: 5147–54. PMID: 26475520",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2015.10.003",
            "pmid": "26475520",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Zhang, C, Li, W. Regioselective synthesis of 6-aryl-benzo [h][1, 2, 4]-triazolo [5, 1-b] quinazoline-7, 8-diones as potent antitumoral agents. Bioorg Med Chem Lett 2013; 23: 5002–5. PMID: 23871222",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2013.06.040",
            "pmid": "23871222",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Schuler, M, Yang, JH, Park, K, et al. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial. Ann Oncol 2016; 27: 417–23. PMID: 26646759",
            "process_entry": "True",
            "doi": "10.1093/annonc/mdv597",
            "pmid": "26646759",
            "pmcid": "PMC4769992",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Lee, CK, Brown, C, Gralla, RJ, et al. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis. J Natl Cancer Inst 2013; 105: 595–605. PMID: 23594426",
            "process_entry": "True",
            "doi": "10.1093/jnci/djt072",
            "pmid": "23594426",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Pao, W, Miller, V, Zakowski, M, et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004; 101: 13306–11. PMID: 15329413",
            "process_entry": "True",
            "doi": "10.1073/pnas.0405220101",
            "pmid": "15329413",
            "pmcid": "PMC516528",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Yin, S, Tang, C, Wang, B, et al. Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo [4, 5-g] quinazolin-2 (1H)-one scaffold. Eur J Med Chem 2016; 120: 26–36. PMID: 27187856",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.04.072",
            "pmid": "27187856",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Ghorab, MM, El Ella, DAA, Heiba, HI, Soliman, AM. Synthesis of certain new thiazole derivatives bearing a sulfonamide moiety with expected anticancer and radiosensitizing activities. J Mater Sci Eng A 2011; 1: 684–91.",
            "process_entry": "True",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "El Ella, DAA, Ghorab, MM, Heiba, HI, Soliman, AM. Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Med Chem Res 2012; 21: 2395–407.",
            "process_entry": "True",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Supuran, CT, Scozzafava, A. Carbonic anhydrase inhibitors. Curr Med Chem Immunol Endocr Metab Agents 2001; 1: 61–97.",
            "process_entry": "True",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Casini, A, Scozzafava, A, Supuran, CT. Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents. Expert Opin Ther Pat 2002; 12: 1307–27.",
            "process_entry": "True",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Villar, R, Encio, I, Migliaccio, M, et al. activity of lipophilic sulphonamide derivatives of the benzo [b] thiophene 1, 1-dioxide. Bioorg Med Chem 2004; 12: 963–8. PMID: 14980609",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2003.12.012",
            "pmid": "14980609",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Payne, JE, Bonnefous, C, Hassig, CA, et al. Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor. Bioorg Med Chem Lett 2008; 18: 6093–6. PMID: 18954983",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2008.10.029",
            "pmid": "18954983",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Wurz, RP, Liu, L, Yang, K, et al. Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1, 3, 5-triazine sulfonamide scaffold. Bioorg Med Chem Lett 2012; 22: 5714–20. PMID: 22832322",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2012.06.078",
            "pmid": "22832322",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Ghorab, MM, Alsaid, MS, Soliman, AM, Ragab, FA. VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo [g] quinazolin bearing benzenesulfonamide moiety. J Enzyme Inhib Med Chem 2017; 32: 893–907. PMID: 28661197",
            "process_entry": "True",
            "doi": "10.1080/14756366.2017.1334650",
            "pmid": "28661197",
            "pmcid": "PMC6445170",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63. PMID: 6606682",
            "process_entry": "True",
            "doi": "10.1016/0022-1759(83)90303-4",
            "pmid": "6606682",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Emily, HYC, Wei, MC, Weiler, S, et al. BCL-2, BCL-X L sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705–11. PMID: 11583631",
            "process_entry": "True",
            "doi": "10.1016/s1097-2765(01)00320-3",
            "pmid": "11583631",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Alnemri, ES, Livingston, DJ, Nicholson, DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171. PMID: 8861900",
            "process_entry": "True",
            "doi": "10.1016/s0092-8674(00)81334-3",
            "pmid": "8861900",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Harrington, HA, Ho, KL, Ghosh, S, Tung, K. Construction and analysis of a modular model of caspase activation in apoptosis. Theor Biol Med Model 2008; 5: 26–41. PMID: 19077196",
            "process_entry": "True",
            "doi": "10.1186/1742-4682-5-26",
            "pmid": "19077196",
            "pmcid": "PMC2672941",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Ghavami, S, Hashemi, M, Ande, SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet 2009; 46: 497–510. PMID: 19505876",
            "process_entry": "True",
            "doi": "10.1136/jmg.2009.066944",
            "pmid": "19505876",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Rudel, T. Caspase inhibitors in prevention of apoptosis. Herz 1999; 24: 236–41. PMID: 10412648",
            "process_entry": "True",
            "doi": "10.1007/bf03044967",
            "pmid": "10412648",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003; 195: 158–67. PMID: 12652643",
            "process_entry": "True",
            "doi": "10.1002/jcp.10254",
            "pmid": "12652643",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Hasnan, J, Yusoff, M, Damitri, T, et al. Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J 2010; 51: 50–6. PMID: 20200776",
            "process_entry": "True",
            "pmid": "20200776",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Callagy, GM, Webber, MJ, Pharoah, PD, Caldas, C. Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 2008; 8: 153–8. PMID: 18510726",
            "process_entry": "True",
            "doi": "10.1186/1471-2407-8-153",
            "pmid": "18510726",
            "pmcid": "PMC2430210",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "McDonnell, TJ, Korsmeyer, SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)). Nature 1991; 349: 254–6. PMID: 1987477",
            "process_entry": "True",
            "doi": "10.1038/349254a0",
            "pmid": "1987477",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Zhu, H, Zhang, J, Xue, N, et al. Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells. Invest New Drugs 2010; 28: 493–501. PMID: 20352291",
            "process_entry": "True",
            "doi": "10.1007/s10637-010-9424-4",
            "pmid": "20352291",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "MacLachlan, TK, Sang, N, Giordano, A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 1995; 5: 127–56. PMID: 8845581",
            "process_entry": "True",
            "doi": "10.1615/critreveukargeneexpr.v5.i2.20",
            "pmid": "8845581",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "DeVita, VT, Lawrence, TS, Rosenberg, SA. Cancer: principles & practice of oncology: primer of the molecular biology of cancer. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.",
            "process_entry": "True",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Stamos, J, Sliwkowski, MX, Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002; 277: 46265–72. PMID: 12196540",
            "process_entry": "True",
            "doi": "10.1074/jbc.m207135200",
            "pmid": "12196540",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Ishikawa, T, Seto, M, Banno, H, et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo [3, 2-d] pyrimidine scaffold. J Med Chem 2011; 54: 8030–50. PMID: 22003817",
            "process_entry": "True",
            "doi": "10.1021/jm2008634",
            "pmid": "22003817",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Lin, J, Shen, W, Xue, J, et al. Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases. Eur J Med Chem 2012; 55: 39–48. PMID: 22818848",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2012.06.055",
            "pmid": "22818848",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Halmos, B, Pennell, NA, Fu, P, et al. Randomized phase II trial of erlotinib beyond progression in advanced erlotinib-responsive non-small cell lung cancer. Oncologist 2015; 20: 1298–303. PMID: 26306902",
            "process_entry": "True",
            "doi": "10.1634/theoncologist.2015-0136",
            "pmid": "26306902",
            "pmcid": "PMC4718423",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Yousuf, Z, Iman, K, Iftikhar, N, Mirza, MU. Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer. Breast Cancer (Dove Med Press) 2017; 9: 447–59. PMID: 28652811",
            "process_entry": "True",
            "doi": "10.2147/BCTT.S132074",
            "pmid": "28652811",
            "pmcid": "PMC5476443",
            "xmlid": "CIT0047"
        }
    ],
    "localid": "MED-31074303",
    "doi": "10.1080/14756366.2019.1609469",
    "pmid": "10.1080/14756366.2019.1609469",
    "pmcid": "31074303",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31074303/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,97)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 1,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,97)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 2,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,97)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,97)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),294,161)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),456,54)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,75)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),77,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),265,148)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),414,134)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),549,146)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),696,105)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),883,85)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),883,85)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,126)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),128,172)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),128,172)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),301,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),301,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0018",
                "rp_string": "18–21",
                "pl_string": "18–21",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),457,155)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 20,
                "xref_id": "",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),457,155)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 21,
                "xref_id": "",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),457,155)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 22,
                "xref_id": "",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),457,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0018",
                "rp_string": "18–21",
                "pl_string": "18–21",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),457,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),717,91)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),717,91)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),809,81)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),891,178)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Molecular hybridization is a simple and effective tool to combine covalently two drug pharmacophores into a single molecule13. Lately, it has been observed that benzo[g]quinazoline and sulphonamides demonstrated profound growth inhibitory activity against different cancer cells and TK enzymes14,15. The quinazoline is a privileged scaffold that constitutes an important class of heterocyclic compounds owing to its varies pharmacological properties16,17. Afatinib, lapatinib, gefitinib, and erlotinib (Figure 1) are the representative drugs in this class in clinical use for targeted anticancer therapies18–21. The use of them has paved the way to develop new quinazoline-based molecules acting as EGFR inhibitors. Also, it is well-known that sulphonamides are strongly related to anticancer activity22,23. They have several targets, most of which are directly connected to oncogenesis24. They proved to exhibit good activity through many mechanisms as carbonic anhydrase24, matrix metalloprotienase25, NADPH reductase26, histone deacetylase27, and PI3K inhibition28.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            },
            {
                "n_rp": 28,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),891,178)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Molecular hybridization is a simple and effective tool to combine covalently two drug pharmacophores into a single molecule13. Lately, it has been observed that benzo[g]quinazoline and sulphonamides demonstrated profound growth inhibitory activity against different cancer cells and TK enzymes14,15. The quinazoline is a privileged scaffold that constitutes an important class of heterocyclic compounds owing to its varies pharmacological properties16,17. Afatinib, lapatinib, gefitinib, and erlotinib (Figure 1) are the representative drugs in this class in clinical use for targeted anticancer therapies18–21. The use of them has paved the way to develop new quinazoline-based molecules acting as EGFR inhibitors. Also, it is well-known that sulphonamides are strongly related to anticancer activity22,23. They have several targets, most of which are directly connected to oncogenesis24. They proved to exhibit good activity through many mechanisms as carbonic anhydrase24, matrix metalloprotienase25, NADPH reductase26, histone deacetylase27, and PI3K inhibition28.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            },
            {
                "n_rp": 29,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),891,178)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Molecular hybridization is a simple and effective tool to combine covalently two drug pharmacophores into a single molecule13. Lately, it has been observed that benzo[g]quinazoline and sulphonamides demonstrated profound growth inhibitory activity against different cancer cells and TK enzymes14,15. The quinazoline is a privileged scaffold that constitutes an important class of heterocyclic compounds owing to its varies pharmacological properties16,17. Afatinib, lapatinib, gefitinib, and erlotinib (Figure 1) are the representative drugs in this class in clinical use for targeted anticancer therapies18–21. The use of them has paved the way to develop new quinazoline-based molecules acting as EGFR inhibitors. Also, it is well-known that sulphonamides are strongly related to anticancer activity22,23. They have several targets, most of which are directly connected to oncogenesis24. They proved to exhibit good activity through many mechanisms as carbonic anhydrase24, matrix metalloprotienase25, NADPH reductase26, histone deacetylase27, and PI3K inhibition28.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            },
            {
                "n_rp": 30,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[14]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),891,178)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Molecular hybridization is a simple and effective tool to combine covalently two drug pharmacophores into a single molecule13. Lately, it has been observed that benzo[g]quinazoline and sulphonamides demonstrated profound growth inhibitory activity against different cancer cells and TK enzymes14,15. The quinazoline is a privileged scaffold that constitutes an important class of heterocyclic compounds owing to its varies pharmacological properties16,17. Afatinib, lapatinib, gefitinib, and erlotinib (Figure 1) are the representative drugs in this class in clinical use for targeted anticancer therapies18–21. The use of them has paved the way to develop new quinazoline-based molecules acting as EGFR inhibitors. Also, it is well-known that sulphonamides are strongly related to anticancer activity22,23. They have several targets, most of which are directly connected to oncogenesis24. They proved to exhibit good activity through many mechanisms as carbonic anhydrase24, matrix metalloprotienase25, NADPH reductase26, histone deacetylase27, and PI3K inhibition28.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            },
            {
                "n_rp": 31,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[15]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),891,178)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Molecular hybridization is a simple and effective tool to combine covalently two drug pharmacophores into a single molecule13. Lately, it has been observed that benzo[g]quinazoline and sulphonamides demonstrated profound growth inhibitory activity against different cancer cells and TK enzymes14,15. The quinazoline is a privileged scaffold that constitutes an important class of heterocyclic compounds owing to its varies pharmacological properties16,17. Afatinib, lapatinib, gefitinib, and erlotinib (Figure 1) are the representative drugs in this class in clinical use for targeted anticancer therapies18–21. The use of them has paved the way to develop new quinazoline-based molecules acting as EGFR inhibitors. Also, it is well-known that sulphonamides are strongly related to anticancer activity22,23. They have several targets, most of which are directly connected to oncogenesis24. They proved to exhibit good activity through many mechanisms as carbonic anhydrase24, matrix metalloprotienase25, NADPH reductase26, histone deacetylase27, and PI3K inhibition28.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),1,106)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),1,106)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[1]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/p),543,155)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "MTT assay"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[4]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[4]/p),167,169)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "The effect on BAX and Bcl-2 levels"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p),71,197)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p),71,197)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[3]/p),1,109)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Activation of caspase-3"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[3]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[3]/p),111,89)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Activation of caspase-3"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[3]/p),201,186)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Activation of caspase-3"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),1,121)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Effects on Bcl-2 family proteins"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),178,99)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Effects on Bcl-2 family proteins"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),278,85)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Effects on Bcl-2 family proteins"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),278,85)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Effects on Bcl-2 family proteins"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),364,134)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Effects on Bcl-2 family proteins"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[5]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[5]/p),284,83)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Cell cycle analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[7]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[7]/p[1]),371,113)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Radiosensitizing evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 48,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[8]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[8]/p),1,134)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Molecular docking"
                ]
            }
        ],
        [
            {
                "n_rp": 49,
                "xref_id": "CIT0045",
                "rp_string": "45",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[9]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[9]/p),109,109)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Docking on EGFR"
                ]
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[9]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[9]/p),219,136)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Docking on EGFR"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p),154,273)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Docking on HER2"
                ]
            }
        ]
    ]
}